Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 32362 [2011-13882]
Download as PDF
32362
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Notices
Enforcement) 101 Market Street, San
Francisco, California 94105–1579:
1. Castle Creek Capital Partners IV,
LP, Castle Creek Advisors IV, LLC,
Castle Creek Capital IV, LLC, John T.
Pietrzak, Pietrzak Advisory Corp., John
M. Eggemeyer, JME Advisory Corp.,
William J. Ruh, Ruh Advisory Corp.,
Mark G. Merlo, Legions IV Advisory
Corp., Joseph Mikesell Thomas, and
Mikesell Advisory Corp., all of Rancho
Santa Fe, California as a group acting in
concert, to acquire control of
Intermountain Community Bancorp,
and thereby indirectly acquire control of
Panhandle State Bank, both of
Sandpoint, Idaho.
Board of Governors of the Federal Reserve
System, June 1, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–13883 Filed 6–3–11; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
jlentini on DSK4TPTVN1PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 1, 2011.
A. Federal Reserve Bank of Richmond
(Adam M. Drimer, Assistant Vice
VerDate Mar<15>2010
16:06 Jun 03, 2011
Jkt 223001
President), 701 East Byrd Street,
Richmond, Virginia 23261–4528:
1. ASB Bancorp, Inc., Asheville,
North Carolina, to become a bank
holding company upon the conversion
of Asheville Savings Bank, S.S.B.,
Asheville, North Carolina, from a
mutual to stock form of ownership.
Board of Governors of the Federal Reserve
System, June 1, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–13882 Filed 6–3–11; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0279]
Agency Information Collection
Activities: Proposed Collection;
Reports and Records Under
Prescription Drug Marketing Act of
1987
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the reporting and recordkeeping
requirements contained in the
regulations implementing the
Prescription Drug Marketing Act of 1987
(PDMA).
DATES: Submit either electronic or
written comments on the collection of
information by August 5, 2011.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
SUMMARY:
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
P150–400B, Rockville, MD 20850, 301–
796–3792,
Elizabeth.Berbakos@fda.hhs.gov.
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes Agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires Federal Agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
Prescription Drug Marketing Act of
1987; Administrative Procedures,
Policies, and Requirements—21 CFR
Part 203 (OMB Control Number 0910–
0435)—Extension
FDA is requesting OMB approval
under the PRA (44 U.S.C. 3501–3520)
for the reporting and recordkeeping
requirements contained in the
regulations implementing the
Prescription Drug Marketing Act of 1987
(PDMA) (Public Law 100–293). PDMA
was intended to ensure that drug
products purchased by consumers are
safe and effective and to avoid an
unacceptable risk that counterfeit,
adulterated, misbranded, subpotent, or
expired drugs are sold.
E:\FR\FM\06JNN1.SGM
06JNN1
Agencies
[Federal Register Volume 76, Number 108 (Monday, June 6, 2011)]
[Notices]
[Page 32362]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-13882]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The application also will be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than July 1, 2011.
A. Federal Reserve Bank of Richmond (Adam M. Drimer, Assistant Vice
President), 701 East Byrd Street, Richmond, Virginia 23261-4528:
1. ASB Bancorp, Inc., Asheville, North Carolina, to become a bank
holding company upon the conversion of Asheville Savings Bank, S.S.B.,
Asheville, North Carolina, from a mutual to stock form of ownership.
Board of Governors of the Federal Reserve System, June 1, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011-13882 Filed 6-3-11; 8:45 am]
BILLING CODE 6210-01-P